These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 18182220)

  • 1. Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system.
    Schmaier AH
    Int Immunopharmacol; 2008 Feb; 8(2):161-5. PubMed ID: 18182220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems.
    Fang C; Schmaier AH
    Pharmacol Res; 2020 Oct; 160():105096. PubMed ID: 32712319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the plasma kallikrein/kinin system on endothelial cell membranes.
    Røjkjaer R; Schmaier AH
    Immunopharmacology; 1999 Sep; 43(2-3):109-14. PubMed ID: 10596841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the plasma kallikrein/kinin system on endothelial cells.
    Rojkjaer R; Schmaier AH
    Proc Assoc Am Physicians; 1999; 111(3):220-7. PubMed ID: 10354362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.
    Schmaier AH
    J Thromb Haemost; 2016 Jan; 14(1):28-39. PubMed ID: 26565070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic activities of the contact activation system.
    Schmaier AH
    Thromb Res; 2014 May; 133 Suppl 1(0 1):S41-4. PubMed ID: 24759141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly and activation of the plasma kallikrein/kinin system: a new interpretation.
    Shariat-Madar Z; Mahdi F; Schmaier AH
    Int Immunopharmacol; 2002 Dec; 2(13-14):1841-9. PubMed ID: 12489798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasma kallikrein-kinin system: its evolution from contact activation.
    Schmaier AH; McCrae KR
    J Thromb Haemost; 2007 Dec; 5(12):2323-9. PubMed ID: 17883591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions.
    Schmaier AH
    Curr Opin Hematol; 2000 Sep; 7(5):261-5. PubMed ID: 10961574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of plasma kallikrein-kinin system inhibitors from salivary glands of the blood-sucking insect Triatoma infestans.
    Isawa H; Orito Y; Jingushi N; Iwanaga S; Morita A; Chinzei Y; Yuda M
    FEBS J; 2007 Aug; 274(16):4271-86. PubMed ID: 17645545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma.
    Johne J; Blume C; Benz PM; Pozgajová M; Ullrich M; Schuh K; Nieswandt B; Walter U; Renné T
    Biol Chem; 2006 Feb; 387(2):173-8. PubMed ID: 16497149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils engage the kallikrein-kinin system to open up the endothelial barrier in acute inflammation.
    Kenne E; Rasmuson J; Renné T; Vieira ML; Müller-Esterl W; Herwald H; Lindbom L
    FASEB J; 2019 Feb; 33(2):2599-2609. PubMed ID: 30281335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel roles for factor XII-driven plasma contact activation system.
    Müller F; Renné T
    Curr Opin Hematol; 2008 Sep; 15(5):516-21. PubMed ID: 18695377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G Protein-Coupled Kinin Receptors and Immunity Against Pathogens.
    Scharfstein J; Ramos PIP; Barral-Netto M
    Adv Immunol; 2017; 136():29-84. PubMed ID: 28950949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory mechanisms of the plasma contact system.
    Maas C; Renné T
    Thromb Res; 2012 May; 129 Suppl 2():S73-6. PubMed ID: 22398015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Factor XII and Kallikrein-Kinin System Combined with Neutrophil Extracellular Trap Formation in Diabetic Retinopathy.
    Song DY; Gu JY; Yoo HJ; Kim YI; Nam-Goong IS; Kim ES; Kim HK
    Exp Clin Endocrinol Diabetes; 2021 Aug; 129(8):560-565. PubMed ID: 31426112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the N-terminal and C-terminal domains of haemaphysalin to inhibition of activation of plasma kallikrein-kinin system.
    Kato N; Okayama T; Isawa H; Yuda M; Chinzei Y; Iwanaga S
    J Biochem; 2005 Sep; 138(3):225-35. PubMed ID: 16169873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.